SCHEMBL7039280

SCHEMBL7039280

CCCc1c(O)ccc2c(Cc3ccccc3)noc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 15/20 0.42
PPARG P37231 14/20 0.42
SHBG P04278 1/20 0.40
MAPK1 P28482 2/20 0.39
HTT P42858 2/20 0.39
POLB P06746 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
JAK2 O60674 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
MPI P34949 1/20 0.39
BLM P54132 1/20 0.39
MCL1 Q07820 1/20 0.39
LMNA P02545 1/20 0.38
TSHR P16473 1/20 0.38
NPY1R P25929 1/20 0.38
AKT1 P31749 1/20 0.38
PPARD Q03181 11/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5208846 0.90 PPARG (0.44) PPARAPPARGKDM4EPPARD
SCHEMBL5210820 0.87 PPARA (0.43) PPARAPPARGPPARD
SCHEMBL7044510 0.87 ALOX5 (0.39) PPARAPPARGPOLBSMN1; SMN2KDM4E
SCHEMBL1995855 0.83 PPARA (0.44) PPARAPPARGPOLBSMN1; SMN2KDM4E
SCHEMBL5210825 0.82 PPARG (0.45) PPARAPPARGPPARD
SCHEMBL5210388 0.80 PPARA (0.41) PPARAPPARGPPARD
SCHEMBL2000748 0.78 GRM2 (0.48) PPARAPPARGPOLBPPARD
SCHEMBL4013334 0.78 PPARA (0.54) PPARAPPARGPPARD
SCHEMBL7039212 0.76 PPARA (0.38) PPARAPPARGPPARD
SCHEMBL1400579 0.76 PPARD (0.39) PPARAPPARGPOLBKDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0882029-B1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO INC (US) 2003-04-02 EP disclosed
US-6090836-A DIETETICS; ADJUSTMENT OF TRIGLYCERIDE CONCENTRATION MERCK & CO., INC. (US) 2000-07-18 US disclosed
EP-0882029-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS Merck & Co., Inc. (US) 1998-12-09 EP disclosed
WO-1997028137-A1 HETEROCYCLIC DERIVATIVES AS ANTIDIABETIC AND ANTIOBESITY AGENTS MERCK & CO., INC. (US) 1997-08-07 WO disclosed